Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 6/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 2/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1845079 | 1.00 | CES1 (0.38) | CES1SRCGSK3BPTPN1MAPK1 | |
| SCHEMBL27700743 | 0.84 | CES1 (0.38) | CES1SRCGSK3BPTPN1MAPK1 | |
| SCHEMBL8071585 | 0.81 | CES1 (0.47) | CES1SRCGSK3BPTPN1MAPK1 | |
| SCHEMBL21753643 | 0.81 | SRC (0.54) | CES1SRCMAPK1HPGDKMT2A | |
| SCHEMBL30006971 | 0.81 | SRC (0.54) | CES1SRCMAPK1HPGDKMT2A | |
| SCHEMBL1846320 | 0.75 | CES1 (0.38) | CES1SRCGSK3BPTPN1MAPK1 | |
| SCHEMBL1846060 | 0.75 | CES1 (0.38) | CES1SRCGSK3BPTPN1MAPK1 | |
| SCHEMBL29634553 | 0.75 | CES1 (0.38) | CES1SRCGSK3BPTPN1MAPK1 | |
| Bromide SCHEMBL30007543 | 0.74 | CES1 (0.37) | CES1SRCGSK3BPTPN1MAPK1 | |
| Bromide SCHEMBL21753647 | 0.74 | CES1 (0.37) | CES1SRCGSK3BPTPN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2320729-B1 | GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | CT SE LLC (US) | 2015-04-22 | — | — | EP | disclosed |
| US-8703723-B2 | Glycoside compounds and pharmaceutical compositions thereof | CENTROSE, LLC (US) | 2014-04-22 | — | — | US | disclosed |
| US-20130178431-A1 | GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | CENTROSE, LLC (US) | 2013-07-11 | — | — | US | disclosed |
| US-8361973-B2 | Glycoside compounds and pharmaceutical compositions thereof | CENTROSE, LLC (US) | 2013-01-29 | — | — | US | disclosed |
| US-20110319350-A1 | GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | CENTROSE, LLC (US) | 2011-12-29 | — | — | US | disclosed |
| EP-2320729-A1 | GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | Centrose, Llc (US) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010017480-A1 | GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | CENTROSE, LLC (US) | 2010-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319350-A1 | GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | UGCG, NFATC1, GAA | CES1 1461/4885SRC 1355/4885GSK3B 505/4885 |
| US-20130178431-A1 | GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | UGCG, NFATC1, GAA | CES1 1461/4885SRC 1355/4885GSK3B 505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.